According to Oncomine (http://www.oncomine.org)16, HOXA5 is highly expressed in AML, gastrointestinal stromal tumors, and glioblastomas, whereas it is weakly expressed in breast, colon, lung, and ovarian cancers. This evidence concerns the gene HOXA5 and glioblastoma.